Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OLMESARTAN | 20MG | TABLET | Resolved | 2018-10-22 | 2020-06-11 | 65350 |
| ACT OLMESARTAN HCT | 25MG 40MG | TABLET | Resolved | 2018-10-22 | 2020-06-11 | 65346 |
| ACT OLMESARTAN HCT | 12.5MG 20MG | TABLET | Resolved | 2018-10-22 | 2020-06-11 | 65343 |
| ACT OLMESARTAN HCT | 12.5MG 40MG | TABLET | Resolved | 2018-09-12 | 2020-06-11 | 61359 |
| ACT OLOPATADINE 0.1% | 0.1% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65519 |
| ACT OLOPATADINE 0.2% | 0.2% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65516 |
| ACT ONDANSETRON | 4MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142607 |
| ACT ONDANSETRON | 8MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142604 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-07-01 | 3381 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3366 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3384 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3377 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-24 | 2017-09-19 | 10978 |
| ACT PIOGLITAZONE | 15MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137882 |
| ACT PIOGLITAZONE | 45MG | TABLET | Resolved | 2024-01-18 | 2025-01-15 | 216454 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2024-05-09 | 2025-01-15 | 227486 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137905 |
| ACT PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-03-12 | 2022-04-21 | 108625 |
| ACT PIOGLITAZONE | 15MG | TABLET | Actual shortage | 2025-08-08 | 2025-10-02 | 264798 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2025-08-08 | 2025-11-13 | 264801 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258522 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258409 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258412 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258405 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258400 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258396 |
| TEVA-ONDANSETRON | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258774 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258729 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258433 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258430 |